Clinical trial
Clinical Study Evaluating the Efficacy and Safety of Metformin Versus Empagliflozin for Halting Chronic Kidney Disease Progression
NCT05373680 is registered in ClinicalTrials.gov with Tanta University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Study Evaluating the Efficacy and Safety of Metformin Versus Empagliflozin for Halting Chronic Kidney Disease Progression
- Lead sponsor
- Tanta University
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- January 1, 2022
- Completion date
- April 1, 2024
- Enrollment
- 118 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.